Optomed PlcStock Exchange Release2 March 2023 at 9.00, Helsinki

Optomed Annual Report 2022 published

Optomed's Annual Report 2022 has been published. The Annual Report includes the company's consolidated and parent company financial statements, the report of the board of directors, the auditor's report, corporate governance statement and remuneration report for governing bodies.

Optomed's Financial Statements are published in accordance with the European Single Electronic Format (ESEF) reporting requirements. In line with the ESEF requirements, the primary statements have been labelled with XBRL tags. Notes to financial statements have been labelled with XBRL block tags. The Financial Statements are attached to this release in xHTML-format.KPMG Oy Ab, authorised public accountants, has provided an independent auditor's reasonable assurance report on Optomed's ESEF Financial Statements in accordance with ISAE 3000.

The Annual Report is attached to this release as a PDF file and it is available in English and Finnish on the corporate website www.optomed.com/investors/. The financial statements are attached as an XHTML file.

Optomed Plc

Further enquiries

Sakari Knuutti, CFO, Optomed Plc, sakari.knuutti@optomed.com

Optomed in Brief

Optomed is a Finnish medical technology company and one of the leading providers of handheld fundus cameras. Optomed combines handheld screening devices fundus cameras with software and artificial intelligence with the aim to transform the diagnostic process of blinding eye-diseases such as rapidly increasing diabetic retinopathy. In its business Optomed focuses on eye-screening devices and software solutions related R&D in Finland and sales through different channels in over 60 countries.